Drug discovery and development using cell-based physiogenomic technologies.

History:

They were acquired by Sequenom (9/2002)

Employment

Email:

Fax:(858) 455-4501

Mail:
Axiom Biotechnologies Inc.
Attn: Kelly Kline
3550 General Atomics Ct.
San Diego, CA 92121-1194

General Info:

Ticker:

Employees:

Regions:

Research Focus:
Disease Therapeutics-Research Therapeutics-Development

 

Profiles: BioSpace Bio.com BioScorpio CHI Network Science

 

News: BioSpace

Keywords: 

Strategic Partnerships: